StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 15/3037% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Workforce dynamics by Year

Workforce dynamics — Global voluntary employee turnover rate (%) (%)

Vertex Pharmaceuticals Workforce dynamics: 5.6% in FY2025, up 1.2 pts from a year earlier.

Latest, FY2025
5.6%
Period ended Dec 31, 2025
Change on a year earlier
+1.2 pts
4.4% in FY2024
History
7 years
Since FY2019
Sources
5
Documents cited below

Where the FY2025 figure comes from

“Voluntary Turnover Rate (Global, Trailing 12 Months Metric) 5.6% 4.4% 4.7%”

Source: Vertex Corporate Responsibility / ESG Report (2025-Vertex-Data-Summary.pdf) ↗

Reported in Vertex Corporate Responsibility & Data Summary Reports.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Vertex Pharmaceuticals Workforce dynamics (%), annual FY2019–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/esg-voluntary-turnover-pct

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.